STORY

From sepsis to cervical cancer: AI helps CU Anschutz save lives

While a recent explosion in AI technology has exposed its possibilities to the public with online systems such as ChatGPT and Dall·E, researchers at the...
STORY

Quantum leap: CU Anschutz set to pioneer advancements in medicine

Last fall, the U.S. Department of Commerce Economic Development Administration designated Colorado’s Elevate Quantum a Regional Technology Hub for Quantum...
STORY

Cardiologist offers Top 10 ways to keep high blood pressure at bay

High blood pressure affects almost half of the U.S. population today, its numbers doubling among 30- to 79-year-olds within the past 20 years. A cardiologist...
STORY

New research gains ground in detecting recent cannabis use

Whether people use cannabis to induce sleep, relieve symptoms or relax during downtime, a vehicle crash or accident at work could leave them in jail or the...
STORY
Science writers amass at CU Anschutz, CU Boulder

Science writers amass at CU Anschutz, CU Boulder

The national Science Writers 2023 conference brought hundreds of science journalists to the CU Anschutz and CU Boulder campuses Oct. 6-10.
STORY

Military standout brings strength to women in medicine

Even with the odds sometimes stacked against them, women can succeed in medicine, a fact that Kathleen Flarity epitomizes and teaches. As burnout in the...
STORY

‘Poisoned’: Assessing the ‘Dirty Truth’ about foodborne illness

“Poisoned: The Dirty Truth About Your Food” has attracted public attention and spoiled more than a few appetites. Safety experts talk about the hits and misses...
STORY
What’s in the forecast for COVID-19?

What’s in the forecast for COVID-19?

A CU Anschutz infectious disease expert and a veteran virologist offer their insights on COVID-19, its circulating strains and an upcoming vaccine.
STORY

CPAP: A first-line sleep apnea therapy fit for a president

A growing number of people are being diagnosed with sleep apnea in the United States, including, it was recently revealed, the president. A sleep doctor talks...
STORY

CU Anschutz takes the reins in CAR T cancer therapy research

Through university and philanthropic support, coupled with the painstakingly challenging work of researchers and staff, the benefits of cell and gene therapy...
STORY

New therapy first to target Type 1 diabetes disease process

A Barbara Davis Center for Diabetes patient became the first person in Colorado to receive a newly approved drug aimed at delaying onset of clinical stage Type...
STORY

Fake news: Medical quackery enters a new dimension

Experts discuss the dangers of the proliferation of health misinformation, pointing largely to threats to patient safety and to evidence-based medicine.
STORY

Near-death experience boosts work to save Black mothers and babies

A CU Anschutz researcher who focuses on maternal mortality and morbidity rates joined the statistics when her own daughter’s birth turned life-threatening. The...
STORY
Bird flu surveillance aims at keeping human risk low

Bird flu surveillance aims at keeping human risk low

A researcher who focuses on human and animal viral intersection explains the need for strong surveillance of the country’s significant avian flu epidemic.
STORY

Can science curb an alcohol use crisis? CU Anschutz addiction experts bank on it

As the nation reels from a substance abuse crisis that’s shattering lives every day, scientists and clinicians across the University of Colorado Anschutz...
STORY

RNA: Star of 2020 promises repeat performances in scientific breakthroughs

A star took center stage at the University of Colorado Anschutz Medical Campus on April 26, where the award-winning “guest” was presented by some of its...
STORY

Can COVID-causing coronavirus outwit human innate immune response?

As Americans cross their fingers, hoping the pandemic stays behind them, scientists across the country remain focused on the novel coronavirus, intent on...
STORY

Solving the puzzle of rare diseases through data and teamwork

Melissa Haendel, PhD, has many goals as a prominent data scientist and the first-ever chief research informatics officer for the University of Colorado...
STORY

Will regulatory change speed discovery of medical CBD benefits?

Artin (Art) Shoukas, PhD, a Johns Hopkins University professor emeritus, would have never dreamed he’d be using marijuana every night in his retirement years...
STORY
New CU School of Pharmacy center sets path toward drug discovery hub

New CU School of Pharmacy center sets path toward drug discovery hub

For today’s generation of medical researchers, the need for speed in the scientific world was never more pronounced than it was in 2020. As society hid from a...
STORY
Mass memorials: A place to grieve, heal, remember

Mass memorials: A place to grieve, heal, remember

Images of the crumbling Twin Towers are invading American living rooms and cellphones, as the 20th anniversary of one of the worst days in the nation’s history...
STORY
Taking aim during mass COVID-19 vaccination campaign: It’s not easy

Taking aim during mass COVID-19 vaccination campaign: It’s not easy

On Dec. 14, when the first COVID-19 vaccine hit Colorado, healthcare providers were cast into another trying mission: Vaccinate the state’s 5.7 million...
STORY
CU Anschutz experts break down COVID-19 effects by body part

CU Anschutz experts break down COVID-19 effects by body part

During the months-long pandemic, healthcare providers have seen a lot of things, often on levels they have never seen before. From brain fog and loss of smell...
STORY
President Trump’s COVID-19 treatment takes the national spotlight

President Trump’s COVID-19 treatment takes the national spotlight

Four clinical trials of a drug cocktail that President Donald Trump has proclaimed his miracle “cure” are underway on the University of Colorado Anschutz...

Pages